Clinical Trial Update: Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update assessing safety and immunogenicity of the A/H1N1-SOIV Swine Flu vaccine with and without adjuvant in children aged 3 to under 9…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine Influenza

Drugs mentioned

• A/H1N1-SOIV Swine Flu Vaccine (Influenza vaccine, inactivated, A/H1N1 swine-origin (SOIV))

Snippet

Sponsor: Novartis Vaccines | Conditions: Influenza | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-01-27